Mirum Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report5 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−11.04%
vs ±9.3% implied · ×1.19
shaded = implied · ▲▼ = realized
No thesis.
Mirum Pharmaceuticals, Inc.
84.74
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Frazier Life Sciences ManagementFrazier Life Sciences | $899.1M | 10.73% | 0.00% | |
| 2 | Jupiter TopcoJupiter Topco | $691.7M | 8.25% | — | |
| 3 | BlackRockBlackRockindex-like | $513.9M | 6.13% | +14.13% | |
| 4 | FMRFMR | $429.7M | 5.13% | +86.75% | |
| 5 | T. Rowe Price AssociatesT. Rowe Price | $310.9M | 3.71% | +54.63% | |
| 6 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $278.3M | 3.32% | +65.98% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $263.9M | 3.15% | −6.65% | |
| 8 | State StreetState Streetindex-like | $254.1M | 3.03% | +11.64% | |
| 9 | William Blair Investment ManagementWilliam Blair | $164.5M | 1.96% | +318.49% | |
| 10 | Geode Capital ManagementGeodeindex-like | $163.2M | 1.95% | +10.63% | |
| 11 | InvescoInvesco | $159.7M | 1.91% | new | |
| 12 | Wellington Management GroupWellington | $153.4M | 1.83% | −1.86% | |
| 13 | Eventide Asset ManagementEventide | $146.2M | 1.74% | −11.39% | |
| 14 | Tang Capital ManagementTang | $144.7M | 1.73% | 0.00% | |
| 15 | Capital World InvestorsCapital World Investors | $135.0M | 1.61% | +59.23% | |
| 16 | Franklin ResourcesFranklin Resources | $135.0M | 1.61% | +61.27% | |
| 17 | NovoNovo | $131.7M | 1.57% | −15.09% | |
| 18 | TCG Crossover ManagementTCG Crossover | $124.3M | 1.48% | 0.00% | |
| 19 | BVFBVF | $123.6M | 1.47% | −33.36% | |
| 20 | Polar Capital HoldingsPolar Capital | $99.0M | 1.18% | +198.26% | |
| 21 | Rock Springs Capital ManagementRock Springs | $93.4M | 1.11% | −1.62% | |
| 22 | Delaware Management HoldingsDelaware | $88.0M | 1.05% | +85.54% | |
| 23 | Ameriprise FinancialAmeriprise Financial | $85.1M | 1.01% | +231.44% | |
| 24 | Two Sigma InvestmentsTwo Sigma | $80.8M | 0.96% | −10.91% | |
| 25 | Bank of New York MellonBank of New York Mellonindex-like | $78.4M | 0.94% | +14.62% |
327 managers report $8.4B of Mirum Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 42 of them hold 80% of it; Frazier Life Sciences is largest at 10.73%.
Linked news
Expected move
No implied move.
No implied move.
No implied move.